Research & Development
Professional, Innovation, and Respect of life
We are a global, new drug developing biopharmaceutical company provide only evidence-based medicine.
Established in 2008, SynCore was cofounded by Sinphar Group and National Health Research Institute (NHRI) Taiwan. We focus on creating values of new drug by R&D management and integration of technology resources. SynCore’s pipeline concentrates on oncology, ophthalmology, and dermatology fields, continuously dedicates in helping patients worldwide.
Taipei, Taiwan, 25 December 2018. SynCore Biotechnology Co. (4192:TT) announces first [...]
SB05 (EndoTAG®-1) is approved to conduct Phase III [...]